| 注册
首页|期刊导航|中华医学杂志(英文版)|Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention

Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention

LIU Xiao-li WANG Zhi-jian YANG Qing YU Miao SHEN Hua NIE Bin HAN Hong-ya GAd Fei ZHOU Yu-jie

中华医学杂志(英文版)2012,Vol.125Issue(6):1051-1056,6.
中华医学杂志(英文版)2012,Vol.125Issue(6):1051-1056,6.DOI:10.3760/cma.j.issn.0366-6999.2012.06.017

Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention

Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention

LIU Xiao-li 1WANG Zhi-jian 1YANG Qing 1YU Miao 1SHEN Hua 1NIE Bin 1HAN Hong-ya 1GAd Fei 1ZHOU Yu-jie1

作者信息

  • 1. Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing 100029, China
  • 折叠

摘要

Abstract

Background Contrast induced acute kidney injury (CIAKI) is an important complication in the use of iodinated contrast media (CM).Our study was to evaluate the neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C for early diagnosis of CIAKI.Methods The patients with established or suspected coronary artery disease (CAD) with the estimated glomerular filtration rate (eGFR) was more than 30 ml.min-1.1.73 m-2 and nor more than 90 ml·min-1·1.73 m-2 were continuously enrolled.The blood samples of the first 50 patients were obtained before and at 2,4,8,24 and 48 hours after procedure to identify the time points at which the biomarkers reached peaks and at which the blood samples of the rest of patients were obtained.The plasma NGAL and cystatin C measure used enzyme-linked immunosorbent assay (ELISA) kit.The diagnostic characteristics of absolute and relative increasing NGAL and cystatin C for CIAKI were evaluated.Results Total 311 patients were enrolled,among whom 39 (12.5%) developed CIAKI.Plasma NGAL increased at 2hours and reached peak at 4 hours after procedure,while plasma cystatin C increased at 2 hours and reached peak at 24hours after procedure.Thus,we determine rational point of time at 4 hours for NGAL and at 24 hours after procedure for cystatin C,respectively.The plasma NGAL at 4 hours after CM exposure showed largest area under curve (AUC) of 0.662 (95% confidence interval (C/):0.565-0.758,P=0.002) with 51.5% sensitivity and 80.6% of specificity.The relative increasing 25% of NGAL showed the best sensitivity and specificity of 0.872 and 0.808,respectively,with maximum Youden index of 0.680,while cystatin C with relative increasing more than 25% had 76.9% of sensitivity and 81.2% of specificity.Combined two biomarkers might get more than 90% of specificity.Conclusions Single measurement of NGAL or cystatin C had poor sensitivity and specificity; however,the relative increasing 25% of NGAL at 4 hours after CM exposure demonstrated higher diagnostic values for CIAKI.Combining relative increasing plasma NGAL with relative increasing plasma cystatin C might perform better for early diagnosis of CIAKI.

关键词

acute kidney injury/early diagnosis/neutrophil gelatinase-associated lipocalin/cystatin C

Key words

acute kidney injury/early diagnosis/neutrophil gelatinase-associated lipocalin/cystatin C

引用本文复制引用

LIU Xiao-li,WANG Zhi-jian,YANG Qing,YU Miao,SHEN Hua,NIE Bin,HAN Hong-ya,GAd Fei,ZHOU Yu-jie..Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention[J].中华医学杂志(英文版),2012,125(6):1051-1056,6.

基金项目

This study was supported by a grant from the National Natural Science Foundation of China (No.81100198). (No.81100198)

中华医学杂志(英文版)

OACSCDCSTPCDMEDLINESCI

0366-6999

访问量3
|
下载量0
段落导航相关论文